Core Insights - Revvity, Inc. (NYSE:RVTY) has launched its new In Vivo Imaging Center of Excellence in Morrisville, North Carolina, aimed at accelerating next-generation imaging innovation [2] - The company plans to enhance disease research workflows through advanced instruments and AI-driven software by integrating teams specializing in various scientific fields [3] - Revvity unveiled several advanced imaging technologies at the new center, which are expected to transform imaging modalities for cancer research and therapeutic efficacy [4] Company Developments - The launch of the In Vivo Imaging Center of Excellence consolidates Revvity's expertise in imaging technologies [2] - The company offers advanced health science solutions across multiple segments, including multi-omics, imaging, biomarkers, and informatics [5] - Revvity's new technologies include IVIS optical systems, Quantum GC3 microCT, Vega preclinical ultrasound, and VivoJect targeted delivery systems [4] Market Position - Revvity is listed among the tech stocks recommended for sale, indicating potential concerns regarding its investment attractiveness [1][5] - Despite acknowledging Revvity's potential, there are suggestions that other AI stocks may offer better upside potential with less downside risk [6]